Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6502
    +0.0013 (+0.20%)
     
  • OIL

    82.93
    -0.43 (-0.52%)
     
  • GOLD

    2,334.80
    -7.30 (-0.31%)
     
  • Bitcoin AUD

    98,927.68
    -3,392.62 (-3.32%)
     
  • CMC Crypto 200

    1,390.47
    -33.63 (-2.36%)
     
  • AUD/EUR

    0.6073
    +0.0017 (+0.28%)
     
  • AUD/NZD

    1.0949
    +0.0019 (+0.17%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,538.55
    +67.08 (+0.38%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,499.10
    -4.59 (-0.01%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

Doximity Stock: Bull vs. Bear

Doximity Stock: Bull vs. Bear

Doximity (NYSE: DOCS), which owns and operates the largest digital platform for U.S. medical professionals, is a prime example. The company's stock price is presently down by an eye-catching 60.9% relative to its all-time highs. Should bargain hunters pounce on this downtrodden growth stock, or is it better to watch this falling knife from the sidelines?